Trexquant Investment LP - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,316,711
+93.7%
183,349
+75.2%
0.21%
+85.0%
Q2 2023$4,292,764
+268.3%
104,625
+220.8%
0.11%
+253.1%
Q1 2023$1,165,553
-34.3%
32,612
-30.5%
0.03%
-36.0%
Q4 2022$1,773,113
-27.9%
46,945
-15.5%
0.05%
-41.9%
Q3 2022$2,458,000
+133.7%
55,564
+95.5%
0.09%
+83.0%
Q2 2022$1,052,000
-40.5%
28,423
-40.5%
0.05%
-43.4%
Q1 2022$1,769,000
+71.4%
47,762
+40.9%
0.08%
+29.7%
Q4 2021$1,032,000
+131.4%
33,903
+155.0%
0.06%
+82.9%
Q3 2021$446,000
-74.6%
13,297
-55.3%
0.04%
-71.3%
Q2 2020$1,755,000
-21.9%
29,759
-37.3%
0.12%
-25.2%
Q1 2020$2,246,000
+206.8%
47,499
+317.3%
0.16%
+147.0%
Q2 2019$732,000
-70.6%
11,383
-62.9%
0.07%
-62.7%
Q1 2019$2,490,000
+968.7%
30,681
+569.9%
0.18%
+176.6%
Q2 2017$233,000
-15.9%
4,580
-33.6%
0.06%
+77.8%
Q1 2017$277,000
-66.9%
6,900
-48.9%
0.04%
-51.4%
Q4 2015$836,00013,5000.07%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders